Brief: Sana Biotechnology Presents Data At ISSCR 2022 Annual Meeting Showing Survival Of Transplanted Hypoimmune Ipsc-Derived Differentiated Cell Types Without Immunosuppression In Non-Human Primates
17/06/2022 14:03
June 17 (Reuters) - Sana Biotechnology Inc SANA.O :
* SANA BIOTECHNOLOGY PRESENTS DATA AT ISSCR 2022 ANNUAL
MEETING
SHOWING SURVIVAL OF TRANSPLANTED HYPOIMMUNE IPSC-DERIVED
DIFFERENTIATED CELL TYPES WITHOUT IMMUNOSUPPRESSION IN NON-HUMAN
PRIMATES
Source text for Eikon: ID:nGNXbDbd28
Further company coverage: SANA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17